V8W-13379-58952
1 vaccination
2 coded responses
8 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 423 / KY
- Registered
- 2021-08-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-14
Registered in v-safe
-
2021-08-14
Dose 1 — Pfizer-BioNTech
- 2021-08-14
-
2021-08-15
Survey response — days 1–6 daily, dose 1MedDRA: Respiratory tract congestion — Feeling: Fair · Site: PainFree text: Head congestionMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-16
Survey response — days 1–6 daily, dose 1MedDRA: Lacrimation increased, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Fever · HeadacheFree text: Major head congestion and runny nose with watery eyesMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-18
- 2021-08-19
- 2021-08-20
- 2021-08-23
- 2021-08-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-14 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Head congestion
Systemic reaction (other): Major head congestion and runny nose with watery eyes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Lacrimation increased | ✓ | · | ✓ |
| SRO | Respiratory tract congestion | ✓ | · | ✓ |
| SRO | Rhinorrhoea | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release